4//SEC Filing
Tocagen Inc 4
Accession 0001209191-17-027908
$FBRXCIK 0001419041operating
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 5:39 PM ET
Size
4.9 KB
Accession
0001209191-17-027908
Insider Transaction Report
Form 4
Tocagen IncTOCA
Duvall Martin J
DirectorChief Executive Officer
Transactions
- Other
Common Stock
2017-04-19$10.00/sh+3,571$35,710→ 3,571 total
Footnotes (1)
- [F1]Represents the conversion of outstanding convertible promissory notes in the aggregate principal amount of $35,000, plus an aggregate of $714.39 accrued interest, into shares of the Issuer's common stock upon closing of the Issuer's initial public offering at a conversion price of $10.00 per share.
Documents
Issuer
Tocagen Inc
CIK 0001419041
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001419041
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 5:39 PM ET
- Size
- 4.9 KB